Preferred Label : Alemtuzumab/Rituximab Regimen;
NCIt synonyms : Rituxan/Campath; Rituximab Plus Alemtuzumab; Rituximab/Alemtuzumab; Alemtuzumab/Rituximab; Rituximab/Alemtuzumab Regimen; Alemtuzumab-Rituximab; Rituximab-Alemtuzumab; Alemtuzumab-Rituximab Regimen;
NCIt related terms : Alemtuzumab and Rituximab; Alemtuzumab and Rituximab-rixa; Alemtuzumab and Rituximab-rixi; Alemtuzumab and Rituximab-rite; Alemtuzumab and Rituximab-blit; Alemtuzumab and Rituximab-arrx; Alemtuzumab and Rituximab-pvvr; Alemtuzumab and Rituximab-abbs;
NCIt definition : A regimen consisting of alemtuzumab and rituximab that can be used for the treatment
of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).;
Codes from synonyms : 12485; 127904; 128532; 128218; 127747; 128375; 128689; 128061;
Origin ID : C181204;
UMLS CUI : C1541186;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
